2H-1,3-benzoxazine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并恶嗪类
• 英文名称: 2H-1,3-benzoxazine
• 化学式: C₈H₇NO
• 分子量: 133.15
• InChiKey: CGACGSHTSCXSSO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  10
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  21.6
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• Substituted 2H-benzoxazin-2-ones
  申请人：UNIROYAL CHEMICAL COMPANY, Inc.

  公开号：EP0289171A1

  公开（公告）日：1988-11-02

  A new class of N-alkyl or N-alkenyl, 2,3-dihydro-­4-thioxo-2H-1,3-benzoxazin-2-ones is disclosed. This class of compounds is useful in the control of plant pests. Thus, pesticidal compositions comprising these benzoxazin-2-ones with a carrier therefor are also described. In addition, a process for forming these benzoxazin-2-one compounds is also set forth.

  揭示了一类新的N-烷基或N-烯基，2,3-二氢-4-硫代-2H-1,3-苯并噁唑-2-酮。这类化合物在植物害虫的控制中很有用。因此，还描述了包含这些苯并噁唑-2-酮和载体的杀虫剂组合物。此外，还提出了一种形成这些苯并噁唑-2-酮化合物的方法。
• ANTIMICROBIAL INDOLINE COMPOUNDS FOR TREATMENT OF BACTERIAL INFECTIONS
  申请人：Gordeev Mikhail Fedorovich

  公开号：US20100069441A1

  公开（公告）日：2010-03-18

  The present invention provides indoline heterocyclic compounds of the following formula I: or pharmaceutically acceptable salts, prodrugs, solvates, or hydrates thereof useful as antibacterial agents, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.

  本发明提供了以下式I的吲哚杂环化合物或其药学上可接受的盐、前药、溶剂合物或水合物，可用作抗菌剂，包含它们的药物组合物，以及使用它们的方法和制备这些化合物的方法。
• [EN] NOVEL COMPOUNDS AND COMPOSITION FOR TARGETED THERAPY OF KIDNEY-ASSOCIATED CANCERS<br/>[FR] NOUVEAUX COMPOSÉS ET COMPOSITION POUR LA THÉRAPIE CIBLÉE DE CANCERS ASSOCIÉS AU REIN
  申请人：MICURX PHARMACEUTICALS INC

  公开号：WO2021150792A1

  公开（公告）日：2021-07-29

  The present invention provides therapeutic compounds of the following formula I: or pharmaceutically acceptable salts, hydrates, or solvates thereof that are therapeutic or anticancer agents, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.

  本发明提供了以下化合物I的治疗性化合物：或其药用可接受的盐、水合物或溶剂合物，这些化合物是治疗性或抗癌剂，包含它们的药物组合物，使用它们的方法，以及制备这些化合物的方法。
• [EN] HETERO RING-FUSED PHENYL COMPOUNDS FOR INHIBITING TNIK AND MEDICAL USES THEREOF<br/>[FR] COMPOSÉS DE PHÉNYLE FUSIONNÉ À UN HÉTÉROCYCLE POUR L'INHIBITION DE TNIK ET UTILISATIONS MÉDICALES ASSOCIÉES
  申请人：KOREA RES INST CHEMICAL TECH

  公开号：WO2019156438A1

  公开（公告）日：2019-08-15

  The present disclosure provides the compound having inhibitory property against TNIK having a specific chemical structure or its pharmaceutically acceptable salt. The present disclosure also provides a composition comprising the compound or its pharmaceutically acceptable salt. The present disclosure also provides a medical use of the compound, its salt or the composition comprising the compound or its pharmaceutically acceptable salt for treating or preventing cancer. The present disclosure also provides a method of treatment or prevention of cancer comprising administering the compound, its salt or the composition comprising the compound or its salt to a subject in need of such treatment or prevention.

  本公开提供具有针对TNIK的抑制性能的化合物，其具有特定的化学结构或其药学上可接受的盐。本公开还提供包括该化合物或其药学上可接受的盐的组合物。本公开还提供了一种利用该化合物、其盐或包括该化合物或其药学上可接受的盐的组合物治疗或预防癌症的医疗用途。本公开还提供了一种治疗或预防癌症的方法，包括向需要此类治疗或预防的受试者施用该化合物、其盐或包括该化合物或其盐的组合物。
• [EN] THIENOPYRROLE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS<br/>[FR] COMPOSÉS DE THIÉNOPYRROLE UTILISÉS COMME INHIBITEURS DE LA S-NITROSOGLUTATHIONE RÉDUCTASE
  申请人：GLENMARK PHARMACEUTICALS SA

  公开号：WO2016128905A1

  公开（公告）日：2016-08-18

  The present disclosure is directed to compounds of formula (Ib) and pharmaceutically acceptable salts thereof, wherein A, Q, R1, R3, R5 and m are as defined herein, which are active as inhibitors of S-Nitrosoglutathione reductase (GSNOR). These compounds prevent, inhibit, or suppress the action of GSNOR and are therefore useful in the treatment of GSNOR mediated diseases, disorders, syndromes or conditions such as, e.g., pulmonary hypertension, acute respiratory distress syndrome (ARDS), asthma, bronchospasm, cough, pneumonia, pulmonary fibrosis, interstitial lung diseases, cystic fibrosis and chronic obstructive pulmonary disease (COPD).

  本公开涉及化合物及其药用盐的公式(Ib)，其中A、Q、R1、R3、R5和m如本文所定义，这些化合物作为S-亚硝基谷胱甘肽还原酶(GSNOR)的抑制剂具有活性。这些化合物可以预防、抑制或抑制GSNOR的作用，因此在治疗GSNOR介导的疾病、疾病、综合征或疾病方面是有用的，例如肺动脉高压、急性呼吸窘迫综合征(ARDS)、哮喘、支气管痉挛、咳嗽、肺炎、肺纤维化、间质性肺疾病、囊性纤维化和慢性阻塞性肺病(COPD)。